Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study.

Zilberberg MD, Nathanson BH, Ditch K, Lawrence K, Olesky M, Shorr AF.

Open Forum Infect Dis. 2019 Nov 25;6(12):ofz504. doi: 10.1093/ofid/ofz504. eCollection 2019 Dec.

2.

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.

Morrissey I, Olesky M, Hawser S, Lob SH, Karlowsky JA, Corey GR, Bassetti M, Fyfe C.

Antimicrob Agents Chemother. 2020 Feb 21;64(3). pii: e01699-19. doi: 10.1128/AAC.01699-19. Print 2020 Feb 21.

3.

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.

Morrissey I, Hawser S, Lob SH, Karlowsky JA, Bassetti M, Corey GR, Olesky M, Newman J, Fyfe C.

Antimicrob Agents Chemother. 2020 Feb 21;64(3). pii: e01715-19. doi: 10.1128/AAC.01715-19. Print 2020 Feb 21.

4.

In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii.

Seifert H, Stefanik D, Olesky M, Higgins PG.

Int J Antimicrob Agents. 2020 Jan;55(1):105829. doi: 10.1016/j.ijantimicag.2019.10.010. Epub 2019 Dec 16.

PMID:
31669740
5.

Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance.

Solomkin JS, Sway A, Lawrence K, Olesky M, Izmailyan S, Tsai L.

Future Microbiol. 2019 Oct;14:1293-1308. doi: 10.2217/fmb-2019-0135. Epub 2019 Oct 1.

PMID:
31570004
6.

Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017.

Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K.

BMC Infect Dis. 2019 Aug 23;19(1):742. doi: 10.1186/s12879-019-4387-3.

7.

National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States.

Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K.

Int J Infect Dis. 2019 Aug;85:203-211. doi: 10.1016/j.ijid.2019.06.017. Epub 2019 Jun 20.

8.

Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits.

Petraitis V, Petraitiene R, Maung BBW, Khan F, Alisauskaite I, Olesky M, Newman J, Mutlib A, Niu X, Satlin M, Singh RS, Derendorf H, Walsh TJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00275-18. doi: 10.1128/AAC.00275-18. Print 2018 Sep.

9.
10.

Evidence for a direct interaction between HSV-1 ICP27 and ICP8 proteins.

Olesky M, McNamee EE, Zhou C, Taylor TJ, Knipe DM.

Virology. 2005 Jan 5;331(1):94-105.

11.

Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors.

Fontaine-Rodriguez EC, Taylor TJ, Olesky M, Knipe DM.

Virology. 2004 Dec 20;330(2):487-92.

12.

Neisseria gonorrhoeae penicillin-binding protein 3 exhibits exceptionally high carboxypeptidase and beta-lactam binding activities.

Stefanova ME, Tomberg J, Olesky M, Höltje JV, Gutheil WG, Nicholas RA.

Biochemistry. 2003 Dec 16;42(49):14614-25.

PMID:
14661974
15.

Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor.

Li Q, Olesky M, Palmer RK, Harden TK, Nicholas RA.

Mol Pharmacol. 1998 Sep;54(3):541-6.

PMID:
9730913

Supplemental Content

Loading ...
Support Center